Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
As the AI era expands, investors are eyeing a broader landscape beyond Nvidia. This article explores a rising AI infr...
An upbeat analyst stance helped lift shares of the first watch restaurant group. This article breaks down the catalys...
Palo Alto Networks stock surged as traders rotated into cybersecurity in a market shifting away from legacy software....
Prices are cooling and mortgage rates linger above historical lows. This piece unpacks whether we’re at a turning poi...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
A 16% dividend raise from American Express has stock watchers talking. This guide breaks down what the move means for...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...
Morgan Stanley and Charles Schwab are integrating direct crypto trading into ordinary brokerage accounts, aiming to c...
In a market obsessed with the next big disruptor, Republic Services stands out as a reliable, cash-generating machine...
A deep dive into AVX Q1 2026 results, revenue streams, and the implications for avax (avx) 2026 earnings. Learn what ...
A celebrity-led passion project climbs to the top on Apple TV, proving that owning your story and diversifying income...